References
- Jabbari M., Cherry R., Lough J. O., Daly D. S., Kinnear D. G., Goresky C. A. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology 1984; 87: 1165–70
- Egger C., Kreczy A., Kirchmair R., Waldenberger P., Jaschke W., Vogel W. Gastric antral vascular ectasia with portal hypertension: treatment with TIPPS. Am J Gastroenterol 1997; 92: 2292–4
- Sebastian S., O'Morain C. A., Buckley M. J. M. Review article: current therapeutic options for gastric antral vascular ectasia. Aliment Pharmacol Ther 2003; 18: 157–65
- Watson M., Hally R. J., McCue P. A., Varga J., Jimenez S. A. Gastric antral vascular ectasia (watermelon stomach) in patients with systemic sclerosis. Arthritis Rheum 1996; 39: 341–6
- Lorenzi A. R., Johnson A. H., Davies G., Gough A. Gastric antral vascular ectasia in systemic sclerosis: complete resolution with methylprednisolone and cyclophosphamide. Ann Rheum Dis 2001; 60: 796–8
- Shibukawa G., Irisawa A., Sakamoto N., Takagi T., Wakatsuki T., Imamura H., et al. Gastric antral vascular ectasia (GAVE) associated with systemic sclerosis: relapse after endoscopic treatment by argon plasma coagulation. Intern Med 2007; 46: 279–83
- Calamia K. T., Scolapio J. S., Viggiano T. R. Endoscopic YAG laser treatment of watermelon stomach (gastric antral vascular ectasia) in patients with systemic sclerosis. Clin Exp Rheumatol 2000; 18: 605–8
- Busteed S., Silke C., Molloy C., Murphy M., Molloy M. G. Gastric antral vascular ectasia – a cause of refractory anemia in systemic sclerosis. Ir Med J 2001; 94: 310
- Marie I., Cailleux N., Hochain P., François A., Metayer J., Levesque H., et al. [Should watermelon stomach be considered to be an unrecognized localization of scleroderma?], French. J Mal Vasc 1996; 21: 188–91
- Kahaleh M. B. Vascular disease is scleroderma. Endothelial T lymphocyte–fibroblast interactions. Rheum Dis Clin North Am 1990; 16: 53–73
- Kuwana M., Okano Y., Kaburaki J., Tojo T., Medsger T. A Jr. Racial differences in the distribution of systemic sclerosis‐related serum antinuclear antibodies. Arthritis Rheum 1994; 37: 902–6
- Nishimagi E., Tochimoto A., Kawaguchi Y., Satoh T., Kuwana M., Takagi K., et al. Characteristics of patients with early systemic sclerosis and severe gastrointestinal tract involvement. J Rheumatol 2007; 34: 2050–5
- Kuwana M., Okano Y., Pandey J. P., Silver R. M., Fertig N., Medsger T. A Jr. Enzyme‐linked immunosorbent assay for detection of anti‐RNA polymerase III antibody: analytical accuracy and clinical association in systemic sclerosis. Arthritis Rheum 2005; 52: 2425–32